0000899243-18-006980.txt : 20180309
0000899243-18-006980.hdr.sgml : 20180309
20180309180050
ACCESSION NUMBER: 0000899243-18-006980
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180307
FILED AS OF DATE: 20180309
DATE AS OF CHANGE: 20180309
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hughes Thomas E.
CENTRAL INDEX KEY: 0001611048
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36510
FILM NUMBER: 18681369
MAIL ADDRESS:
STREET 1: C/O ZAFGEN, INC.
STREET 2: ONE BROADWAY, 8TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ZAFGEN, INC.
CENTRAL INDEX KEY: 0001374690
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 203857670
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 175 PORTLAND STREET
STREET 2: 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02114
BUSINESS PHONE: 617-622-4003
MAIL ADDRESS:
STREET 1: 175 PORTLAND STREET
STREET 2: 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02114
FORMER COMPANY:
FORMER CONFORMED NAME: ZAFGEN INC
DATE OF NAME CHANGE: 20060906
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-03-07
0
0001374690
ZAFGEN, INC.
ZFGN
0001611048
Hughes Thomas E.
C/O ZAFGEN, INC.
175 PORTLAND STREET, 4TH FLOOR
BOSTON
MA
02114
1
1
0
0
See Remarks
Common Stock
2018-03-07
4
S
0
5000
10.00
D
157247
D
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Includes 4,876 shares acquired under the employee stock purchase plan purchased in July 2017 and in January 2018.
President and Chief Scientific Officer
/s/ Laurie Burlingame (Attorney-In-Fact)
2018-03-09